Explore the complete record of transactions filed by Brooks Michael J, Président. Director active across 1 companies, notably Edesa Biotech, Inc.. In total, 6 disclosures have been published. Total volume traded: €24k. The latest transaction was disclosed on 29 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Michael J. Brooks is the President of Edesa Biotech, Inc. In this role, he is responsible for the strategic direction of the company and key decision-making. Michael plays an essential role in product development and guiding research and development initiatives. His leadership is crucial for ensuring Edesa Biotech's growth and success. He works closely with teams to achieve business objectives and improve outcomes for shareholders.